Adults living with HIV who receive antiretroviral therapy exhibit significantly higher thyroid-stimulating hormone levels than those who are therapy-naïve, according to a cross-sectional study conducted in Kisumu County, Western Kenya. In the cross-sectional evaluation, ART-treated participants had higher serum TSH concentrations than ART-naïve subjects, registering 1.72 (1.71) mIU/L compared to 0.87 (1.07) mIU/L among the untreated comparison group. This observed elevation in thyroid-stimulating hormone was statistically significant, with a reported P-value of 0.010.
The cross-sectional study was established to examine endocrine and lipid patterns in a regional setting where previous clinical data had been limited. While antiretroviral therapy has successfully reduced HIV mortality, dyslipidaemia and thyroid dysfunction are increasingly observed among individuals receiving therapy. Despite these broader clinical observations across treated populations, the specific effects of antiretroviral treatment on thyroid function and circulating lipid profiles in Kisumu County had remained unclear prior to this cross-sectional investigation.
To address this question, researchers assessed serum lipids and thyroid hormones across a study cohort comprising 84 ART-treated subjects and 20 ART-naïve subjects living with HIV. The investigative team evaluated thyroid status by measuring circulating concentrations of thyroid-stimulating hormone (TSH), thyroxine (T4), and triiodothyronine (T3). In parallel, the researchers examined lipid profiles by measuring total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) across all participating adults.
The biological markers were assessed in serum samples using colorimetric and immunofluorescence laboratory methods. Statistical evaluations comparing the ART-treated and ART-naïve groups were conducted using the non-parametric Mann–Whitney U test, while correlations between parameters were evaluated using Spearman’s correlation tests. Beyond the significant increase observed in TSH levels, the statistical comparisons indicated that circulating levels of T4, HDL, total cholesterol, triglycerides, and LDL did not differ significantly between the ART-treated and ART-naïve individuals.
Although comparisons between treatment groups revealed no significant differences in circulating lipid fractions, correlation analysis identified an association between thyroid hormone levels and lipid parameters. Using Spearman’s correlation tests, the researchers observed that thyroxine (T4) was positively correlated with low-density lipoprotein (LDL), a relationship that was statistically significant with P = 0.014. In their conclusion, the authors noted that antiretroviral therapy is linked to elevated TSH and advised that routine lipid and thyroid monitoring should be conducted for adults living with HIV.
Subject of Research: Thyroid hormone and lipid profiles in ART-treated and ART-naïve adults living with HIV
Article Title: Thyroid hormones and lipid profiles in ART-treated versus ART-naïve adults living with HIV: a cross-sectional study in Western Kenya
Article References: O. Alfred, J., Elly, M. O., Magak, N. G., & Owiti, M. G. (2026). Thyroid hormones and lipid profiles in ART-treated versus ART-naïve adults living with HIV: a cross-sectional study in Western Kenya. AIDS Research and Therapy. https://doi.org/10.1186/s12981-026-00965-3
Image Credits: AI Generated
DOI: 10.1186/s12981-026-00965-3
Keywords: antiretroviral therapy, HIV, thyroid-stimulating hormone, TSH, thyroxine, triiodothyronine, lipid profiles, dyslipidaemia, thyroid dysfunction, Kisumu County, Western Kenya, total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein, cross-sectional study, immunofluorescence, colorimetric assay

